1Pass R H, Trivedi K R, Hsu D T. A new technique for endomyc cardial biopsy in infants and small children [J]. Catheler Cardiovasc Intery, 2000,50(4) :441--444.
2Sauvant G, Bossart W, Kurrer M O, et al. Diagnosis and course of myocarditis: a survey in the medical clinics of Zurich University Hospital 1980 to 1998[J]. Schweiz Med Wochenschr, 2000, 130 (36) : 1265-- 1271.
3i.auer B, Niederau C, Ktihl U, et al. Cardiac troponin T in the di agnosis and follow up of suspected myocarditis [J]. Dtsch Med Wochensehr, 1998,123(14) :409--417.
4Ishii J, Nomura M, Nakamura Y, et al. Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heartfailure[J]. Am J Cardiol, 2002,89:691.
5Drucker N A, Colan S D, Lewis A B, et al. γ--Globulin treatment of acute myocarditis in the pediatric population[J]. Circulation, 1994, 89(1): 252.
6Martino T A, Petric M, Brown M, et al. Cardiovvirulent coxsack- ieviruses and the decay--accelerating factor(CD55)receptor[J]. Vi rology, 1998,244(2) : 302-- 314.
7Matsumori A, Nunokawa Y, Yamaki A, et al. Suppression of cy- tokines and nitric oxide production and protection against lethal en- dotoxemia and viral myocarditis by a new NF kappa B inhibitor[J]. Eur J Heart Fail,2004,6(2) :137--144.
8Kato S, Morimoto S, Hiramitsu S, et al. Successful high--dose in- travenous immunoglobulin therapy for a patient[J]. Heart Ves sels,2007 ,22:48--51.
10Grn,S,Schumm,J,Greulich S.Long-term follow-up of biopsy-proven viral myocarditis:Predictors of mortality and incompleterecovery[J].J Am College of Cardiology,2012,59(18):912-913.
